CXS chemgenex pharmaceuticals ltd
Add to My Watchlist 0.00% ! 70.0¢

promising biotech

  1. malmanu
    16,962 Posts.
    lightbulb Created with Sketch. 844
    clock Created with Sketch.
    16/03/11
    23:30
    Post #: 8066094
    Oncology company Chemgenex Pharmaceuticals (CXS) is also on track again with the FDA. The company is expected to resubmit its new drug application in the first half of 2011 for Omapro, for the treatment of chronic myeloid leukaemia




    http://www.asx.com.au/resources/newsletters/investor_update/20110111_9_promising_biotechs.htm
    CXS Price at posting: 44.0¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 2  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

AGC Strong near-surface gold results strengthen Achilles fundamentals for AGC
right-arrow Created with Sketch.
NEWS Vulcan signs first major Phase One contract with NESI
right-arrow Created with Sketch.
NEWS Stay ahead - view the latest ASX market news
right-arrow Created with Sketch.
NEWS Rubix advances proposed acquisition of prospective Bauxite Projects in Africa
right-arrow Created with Sketch.
NEWS Final toll milling completed at Jeffreys Find Gold Mine
right-arrow Created with Sketch.
NEWS Arrowsmith North Silica Sand Project granted works approval
right-arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.